Does Rallies show Form 4 insider transactions for ARAY?

Yes. Rallies tracks ARAY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ARAY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARAY. It does not provide personalized investment advice.

ARAY (Accuray Incorporated) Stock Analysis - Insider Trades

Accuray Incorporated (ARAY) is a publicly traded Healthcare sector company. As of May 21, 2026, ARAY trades at $0.31 with a market cap of $34.82M and a P/E ratio of -0.86. ARAY moved +15.01% today. Year to date, ARAY is -62.47%; over the trailing twelve months it is -80.88%. Its 52-week range spans $0.25 to $2.95. Analyst consensus is neutral with an average price target of $0.35. Rallies surfaces ARAY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ARAY stock inside the company?

Recent ARAY insider activity includes MAYER STEVEN F bought 54.88K, MAYER STEVEN F bought 69.00K, MAYER STEVEN F bought 126.13K, La Neve Stephen R. bought 20.00K, and WHITTERS JOSEPH E bought 50.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ARAY Key Metrics

Key financial metrics for ARAY
Metric	Value
Price	$0.31
Market Cap	$34.82M
P/E Ratio	-0.86
EPS	$-0.38
Dividend Yield	0.00%
52-Week High	$2.95
52-Week Low	$0.25
Volume	201.99K
Avg Volume	0
Revenue (TTM)	$428.57M
Net Income	$-46.13M
Gross Margin	26.92%

Recent ARAY Insider Trades

MAYER STEVEN F bought 54.88K (~$30.88K) on Feb 20, 2026.
MAYER STEVEN F bought 69.00K (~$36.60K) on Feb 19, 2026.
MAYER STEVEN F bought 126.13K (~$67.20K) on Feb 18, 2026.
La Neve Stephen R. bought 20.00K (~$19.41K) on Nov 19, 2025.
WHITTERS JOSEPH E bought 50.00K (~$62.33K) on Jun 13, 2025.

Latest ARAY News

Accuray Q3 Revenue Falls 7% to $104.8M, Guidance Withdrawn — May 6, 2026
Accuray Taps Paul Miele as Chief Commercial Officer after Driving Double-Digit J&J MedTech Sales Growth — Apr 6, 2026
Accuray Q2 Revenue Drops to $102.2M, EPS Misses, $6.1M Restructuring Charges — Feb 5, 2026

ARAY Analyst Consensus

2 analysts cover ARAY: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.35.

Common questions about ARAY

Who is trading ARAY stock inside the company?: Recent ARAY insider activity includes MAYER STEVEN F bought 54.88K, MAYER STEVEN F bought 69.00K, MAYER STEVEN F bought 126.13K, La Neve Stephen R. bought 20.00K, and WHITTERS JOSEPH E bought 50.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ARAY?: Yes. Rallies tracks ARAY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ARAY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARAY. It does not provide personalized investment advice.